Vanderbilt University

The US Food and Drug Administration approvals of Vertex Pharmaceuticals Incorporated /C CRISPR Therapeutics AG ’s gene editing medicine Casgevy (exagamglogene-autotemcel, exa-cel) and bluebird bio i

The approval of the first genetic medicines for sickle cell disease (SCD) on the eve of the American Society of Hematology (ASH) annual meeting set off a celebratory feel for the conference, held 9-12

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M

Amylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch